Galante Joseph C's Form 4 filing
Cumberland Pharmaceuticals Inc (CPIX) ยท filed Aug 13, 2021
- Accession no.
- 0001209191-21-051441
- Filed
- Aug 13, 2021
- Trade date
- Jul 8-30, 2021
- Filing delay
- 36 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 17 non-derivative transactions. Open-market purchases total $8.00K. It was filed 36 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Galante Joseph CCIK 0001632384 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 8, 2021 | Common Stock | PPurchaseAcquired | +142 | $3.18 | +$451.56 | 32,559 | Direct | |
| Jul 9, 2021 | Common Stock | PPurchaseAcquired | +142 | $3.13 | +$444.46 | 32,701 | Direct | |
| Jul 12, 2021 | Common Stock | PPurchaseAcquired | +142 | $3.33 | +$472.86 | 32,843 | Direct | |
| Jul 13, 2021 | Common Stock | PPurchaseAcquired | +142 | $3.48 | +$494.16 | 32,985 | Direct | |
| Jul 14, 2021 | Common Stock | PPurchaseAcquired | +142 | $3.33 | +$472.86 | 33,127 | Direct | |
| Jul 15, 2021 | Common Stock | PPurchaseAcquired | +142 | $3.27 | +$464.34 | 33,269 | Direct | |
| Jul 16, 2021 | Common Stock | PPurchaseAcquired | +142 | $3.28 | +$465.76 | 33,411 | Direct | |
| Jul 19, 2021 | Common Stock | PPurchaseAcquired | +142 | $3.23 | +$458.66 | 33,553 | Direct | |
| Jul 20, 2021 | Common Stock | PPurchaseAcquired | +142 | $3.24 | +$460.08 | 33,695 | Direct | |
| Jul 21, 2021 | Common Stock | PPurchaseAcquired | +142 | $3.26 | +$462.92 | 33,837 | Direct | |
| Jul 22, 2021 | Common Stock | PPurchaseAcquired | +142 | $3.36 | +$477.12 | 33,979 | Direct | |
| Jul 23, 2021 | Common Stock | PPurchaseAcquired | +142 | $3.35 | +$475.7 | 34,121 | Direct | |
| Jul 26, 2021 | Common Stock | PPurchaseAcquired | +142 | $3.39 | +$481.38 | 34,263 | Direct | |
| Jul 27, 2021 | Common Stock | PPurchaseAcquired | +142 | $3.39 | +$481.38 | 34,405 | Direct | |
| Jul 28, 2021 | Common Stock | PPurchaseAcquired | +142 | $3.42 | +$485.64 | 34,547 | Direct | |
| Jul 29, 2021 | Common Stock | PPurchaseAcquired | +142 | $3.42 | +$485.64 | 34,689 | Direct | |
| Jul 30, 2021 | Common Stock | PPurchaseAcquired | +142 | $3.31 | +$470.02 | 34,831 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.